NCT00301028 · OUTCOME

Number of Participants With Complete Response

Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer · Source last updated 2013-04-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: participants
Interval / dispersion: Not reported
Time frame: Study period of 3 Years

What was measured

Number of participants with a complete response. Complete Response (CR): Disappearance of clinical and radiological evidence of tumor.

Groups in this outcome

Cetuximab + Carboplatin/Paclitaxel

Cetuximab beginning weekly dose 400 mg/m\^2 intravenous (IV), and 250 mg/m\^2 weeks 2-6; Weekly Carboplatin AUC 2 and Paclitaxel 135 mg/m\^2 for 6 courses.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Cetuximab + Carboplatin/Paclitaxel	47

Reported measurements

Source class 1

Values in participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Cetuximab + Carboplatin/Paclitaxel	39	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
39

denoms

counts
group Id
OG000
value
47
units
Participants

description

Number of participants with a complete response. Complete Response (CR): Disappearance of clinical and radiological evidence of tumor.

groups

description
Cetuximab beginning weekly dose 400 mg/m\^2 intravenous (IV), and 250 mg/m\^2 weeks 2-6; Weekly Carboplatin AUC 2 and Paclitaxel 135 mg/m\^2 for 6 courses.
id
OG000
title
Cetuximab + Carboplatin/Paclitaxel

param Type

NUMBER

reporting Status

POSTED

time Frame

Study period of 3 Years

title

Number of Participants With Complete Response

type

PRIMARY

unit Of Measure

participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice